CGAS and tauopathy: Sequencing results from hippocampal tissue in a tau-induced disease model revealed elevated levels of cGAS and STING, while genetic ablation of cGAS in mice with tauopathy alleviated the activation of IFN-I response in microglia, without altering the pathological tau load in the brain.